Published online Sep 6, 2021. doi: 10.12998/wjcc.v9.i25.7381
Peer-review started: June 15, 2021
First decision: June 24, 2021
Revised: July 1, 2021
Accepted: July 14, 2021
Article in press: July 14, 2021
Published online: September 6, 2021
Processing time: 76 Days and 18.7 Hours
At present, there is controversy on the role of microvessel density (MVD) in tumors as a prognostic indicator of bladder transitional cell carcinoma (BTCC).
The MVD in tumors is simply classified based on the expression of several different vascular markers, which has not been related to analytical research on the prognosis of patients with BTCC.
This study aimed to explore the classification of blood vessels in tumors and studied the relationship between MVD and the prognosis of patients with BTCC.
We investigated the MVD in BTCC through tissue microarray and immunohistochemical analyses. By observing the morphological characteristics of blood vessels and the expression of specific markers, we explored the classification of blood vessels in tumors and studied the relationship between MVD and the prognosis of patients.
Two different types of microvessels in BTCC were identified as undifferentiated (CD31+/CD34-) vessels and differentiated (CD34+) vessels. The MVD of high-grade undifferentiated vessels was positively correlated with a higher tumor grade and shorter survival time of the patients. In contrast, the MVD of high-grade differentiated vessels was positively correlated with lower-grade tumors and longer survival time of the patients. Multivariate analysis showed that undifferentiated MVD was an independent prognostic factor for patient survival time. An inverse correlation between undifferentiated tumor MVD and differentiated tumor MVD in BTCC was also shown.
This was the first report on the correlation between two microvascular types and the prognosis of patients with BTCC. The results showed that the classification of blood vessels in BTCC could act as an important prognostic indicator and may also be of great significance in the treatment of cancer.
Our research is helpful for clinical treatment, and suggests that undifferentiated blood vessels may be a potential target for vascular treatment. Therefore, in research on anti-angiogenic drugs, drug research targeting undifferentiated blood vessels or differentiated blood vessels or both blood vessels may be a future research direction.